E-ISSN 1309-4866
RELATED ARTICLES
Other
The Intersexual Differences of Sexual Functions and Prolactine Levels in Schizophrenia Patients Under Antipsychotic Medication
(Arch Neuropsychiatry 2011; 48: 35-38)
DOI: 10.4274/npa.y6076
Research Article
Association Between Age at Onset of Schizophrenia and Age at Menarche
(Arch Neuropsychiatry 2014; 51: 211-215)
DOI: 10.4274/npa.y6675
Are Uric Acid Levels Different from Healthy Subjects in Bipolar Affective Disorder and Schizophrenia?: Relationship Between Clinical Improvement and Episode Severity in Male Patients
(Arch Neuropsychiatry 2014; 51: 229-232)
DOI: 10.4274/npa.y6827
Antipsychotic Use Pattern in People with Psychotic Disorder Living in Board and Care Facilities
(Arch Neuropsychiatry 2015; 52: 145-150)
DOI: 10.5152/npa.2015.7419
Relationship Suicide, Cognitive Functions, and Depression in Patients with Schizophrenia
(Arch Neuropsychiatry 2015; 52: 169-173)
DOI: 10.5152/npa.2015.7506
Prevalence of Substance Use in Patients Diagnosed with Schizophrenia
(Arch Neuropsychiatry 2016; 53: 4-11)
DOI: 10.5152/npa.2015.8827
Structuring of the Bakırköy Rehabilitation Form for Patient with Chronic Mental Illness
(Arch Neuropsychiatry 2010; 47: 183-195)
DOI: 10.4274/npa.5403
Burden on Caregivers of Patients with Schizophrenia and Related Factors
(Arch Neuropsychiatry 2016; 53: 96-101)
DOI: 10.5152/npa.2015.9963
Comparison between Camberwell Family Interview and Expressed Emotion Scale in Determining Emotions of Caregivers of Schizophrenic Patients
(Arch Neuropsychiatry 2013; 50: 301-305)
DOI: 10.4274/npa.y5832
The Relation Between Functional Anatomy of the Face and Threat Perception Evoked by Facial Expression of Anger in Schizophrenia
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2017.21632
Predictors of Subjective Quality of Life in Schizophrenia Patients and Their Relatives: A Follow-up Study
(Arch Neuropsychiatry 2010; 47: 292-296)
DOI: 10.4274/npa.y5521
Antipsychotic Polypharmacy in Schizophrenic Inpatients
(Arch Neuropsychiatry 2010; 47: 23-28)
Sociodemographic and Clinical Characteristics of Involuntary and Voluntary Hospitalized Psychiatric Inpatients in a Mental Health Hospital
(Arch Neuropsychiatry 2013; 50: 216-221)
DOI: 10.4274/npa.y6245
Severity of Minor Physical Anomalies as a Possible Trait Marker in Schizophrenia
(Arch Neuropsychiatry 2012; 49: 188-191)
DOI: 10.4274/npa.y6148
Comparison of the Schizotypal Features of First-Degree Relatives of Schizophrenic Patients with Those of Healthy Controls
(Arch Neuropsychiatry 2012; 49: 266-271)
DOI: 10.4274/npa.y6136
Pimozide Augmentation Therapy in Treatment-Resistant Schizophrenia Patients with Poor or Partial Response to Clozapine: A Retrospective Study
(Arch Neuropsychiatry 2010; 47: 302-306)
DOI: 10.4274/npa.y5570
Potential Risk Factors for Schizophrenia
(Arch Neuropsychiatry 2010; 47: 230-236)
DOI: 10.4274/npa.5486
A Study on Validity and Reliability of the Turkish Version of the Perceived Family Burden Scale
(Arch Neuropsychiatry 2011; 48: 53-58)
DOI: 10.4274/npa.y5617
Symptomatic Remission Determines Functional Improvement and Quality of Life in Schizophrenia
(Arch Neuropsychiatry 2016; 53: 328-333)
DOI: 10.5152/npa.2016.11327
Social Cognition in Schizophrenia Patients and Their First-Degree Relatives
(Arch Neuropsychiatry 2016; 53: 338-343)
DOI: 10.5152/npa.2016.10223
Clinical, Neurocognitive, Structural Imaging and Dermatogliphics in Schizophrenia According to Kraepelin Criteria
(Arch Neuropsychiatry 2013; 50: 256-262)
DOI: 10.4274/npa.y6504
Theory of Mind and Selective Attention, Response Inhibition, Cognitive Flexibility in Patients with Schizophrenia
(Arch Neuropsychiatry 2017; 54: 162-167)
DOI: 10.5152/npa.2016.12750
Relationship between Antidepressant Prescription Rates and Features of Schizophrenic Patients and Its Outcome in Schizophrenia Treatment
(Arch Neuropsychiatry 2015; 52: 64-68)
DOI: 10.5152/npa.2015.7041
Premorbid Personality Disorders in Male Schizophrenic Patients with or without Comorbid Substance Use Disorder: Is Dual Diagnosis Mediated by Personality Disorder?
(Arch Neuropsychiatry 2015; 52: 303-308)
DOI: 10.5152/npa.2015.7679
The Validity and Reliability of the Turkish Version of Drug Attitude Inventory-10
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2017. 18078
Is There any Relation Between Impaired Emotion Perception and Thought Disorder in Schizophrenia?
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2017.19277
Case Report
Blindness as a Result of Self-Enucleation: Three Schizophrenia Cases
(Arch Neuropsychiatry 2012; 49: 152-156)
DOI: 10.4274/npa.y5656
Augmentation of Clozapine with Pimozide: A Case of a Treatment-Resistant Schizophrenic Patient
(Arch Neuropsychiatry 2010; 47: 74-77)
Idiopathic Hypoparathyroidism (IHP) Presenting as “Schizophrenia:” A Case Report
(Arch Neuropsychiatry 2014; 51: 401-402)
DOI: 10.5152/npa.2014.7155
Hypomania in a Schizophrenic Patient Treated with Modafinil for Clozapine-Induced Sedation
(Arch Neuropsychiatry 2010; 47: 171-173)
DOI: 10.4274/npa.5474
Menstrual Cycle in Schizophrenic Patients: Review with a Case
(Arch Neuropsychiatry 2015; 52: 417-419)
DOI: 10.5152/npa.2015.7660
Review
Evaluation of the Psychodynamic Aspects of Somatization in Schizophrenia Patients
(Arch Neuropsychiatry 2009; 46: 110-114)
Schizophrenia and Bipolar Disorder In Terms of Cognitive Impairments; Similarities and Differences - A Systematic Review
(Arch Neuropsychiatry 2010; 47: 150-157)
DOI: 10.4274/npa.5624
Key Words
Authors
All
Author's Corner
Announcements
Survey
AVES | Copyright © 2017 Turkish Neuropsychiatric Society | Latest Update: 03.10.2017